Glutamine

"Glutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.

Descriptor ID	D005973
MeSH Number(s)	D12.125.068.330 D12.125.095.461 D12.125.154.424
Concept/Terms	Glutamine Glutamine L-Glutamine L Glutamine D-Glutamine D-Glutamine D Glutamine

Below are MeSH descriptors whose meaning is more general than "Glutamine".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Amino Acids [D12.125]
Amino Acids, Basic [D12.125.068]
Glutamine [D12.125.068.330]
Amino Acids, Diamino [D12.125.095]
Glutamine [D12.125.095.461]
Amino Acids, Neutral [D12.125.154]
Glutamine [D12.125.154.424]

Below are MeSH descriptors whose meaning is related to "Glutamine".

Below are MeSH descriptors whose meaning is more specific than "Glutamine".

Glutamine
Proglumide

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glutamine" by people in this website by year, and whether "Glutamine" was a major or minor topic of these publications.

Bar chart showing 35 publications over 22 distinct years, with a maximum of 3 publications in 2003 and 2014 and 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1997	1	0	1
1998	0	1	1
1999	1	0	1
2000	1	1	2
2001	0	1	1
2003	1	2	3
2004	0	2	2
2007	0	2	2
2008	1	0	1
2009	1	0	1
2011	1	1	2
2012	1	0	1
2013	0	1	1
2014	1	2	3
2015	2	1	3
2016	1	1	2
2018	1	1	2
2019	1	1	2
2020	1	0	1
2021	1	0	1
2022	1	0	1

Below are the most recent publications written about "Glutamine" by people in Profiles.

Kami Reddy KR, Piyarathna DWB, Park JH, Putluri V, Amara CS, Kamal AHM, Xu J, Kraushaar D, Huang S, Jung SY, Eberlin LS, Johnson JR, Kittles RA, Ballester LY, Parsawar K, Siddiqui MM, Gao J, Langer Gramer A, Bollag RJ, Terris MK, Lotan Y, Creighton CJ, Lerner SP, Sreekumar A, Kaipparettu BA, Putluri N. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. JCI Insight. 2024 Sep 10; 9(17).

View in: PubMed
Hatipoglu A, Menon D, Levy T, Frias MA, Foster DA. Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells. PLoS One. 2022; 17(10):e0276579.

View in: PubMed
Weaver SB, Rungkitwattanakul D, Singh D. Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease. J Pharm Pract. 2023 Feb; 36(1):139-148.

View in: PubMed
Srivastava S, Widmann S, Ho C, Nguyen D, Nguyen A, Premaratne A, Gustafsson J?, Lin CY. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells. Int J Mol Sci. 2020 Dec 17; 21(24).

View in: PubMed
Han J, Saraf SL, Gordeuk VR. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease. Pharmacotherapy. 2020 06; 40(6):535-543.

View in: PubMed
Ke T, Sidoryk-Wegrzynowicz M, Pajarillo E, Rizor A, Soares FAA, Lee E, Aschner M. Role of Astrocytes in Manganese Neurotoxicity Revisited. Neurochem Res. 2019 Nov; 44(11):2449-2459.

View in: PubMed
Bernfeld E, Foster DA. Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells. Trends Endocrinol Metab. 2019 06; 30(6):357-368.

View in: PubMed
Bernfeld E, Menon D, Vaghela V, Zerin I, Faruque P, Frias MA, Foster DA. Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine. J Biol Chem. 2018 10 19; 293(42):16390-16401.

View in: PubMed
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19; 379(3):226-235.

View in: PubMed
Chen L, Xu X, Zeng H, Chan KWY, Yadav N, Cai S, Schunke KJ, Faraday N, van Zijl PCM, Xu J. Separating fast and slow exchange transfer and magnetization transfer using off-resonance variable-delay multiple-pulse (VDMP) MRI. Magn Reson Med. 2018 10; 80(4):1568-1576.

View in: PubMed

People

Explore

Similar Concepts

Top Journals